Propofol Reduces Microelectrode-Recording Artefacts caused by Parkinsonian Tremor during Deep Brain Stimulation

Jason Chui; Rizq Alamri; Frank Bihari; Matthew Hebb; Lakshmikumar Venkatraghavan

doi:10.1055/s-0037-1618321

Journal of Neuroanaesthesiology and Critical Care, Inhaltsverzeichnis

CC-BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2018; 05(01): 21-25
DOI: 10.1055/s-0037-1618321

Case Report

Thieme Medical and Scientific Publishers Private Limited

Propofol Reduces Microelectrode-Recording Artefacts caused by Parkinsonian Tremor during Deep Brain Stimulation

Jason Chui

¹Department of Anesthesia and Perioperative Medicine, Schulich School of Medicine and Dentistry, Western University, Ontario, Canada

,

Rizq Alamri

¹Department of Anesthesia and Perioperative Medicine, Schulich School of Medicine and Dentistry, Western University, Ontario, Canada

,

Frank Bihari

²Department of Neurophysiology, University of Western Ontario, Ontario, Canada

,

Matthew Hebb

³Department of Clinical Neurological Sciences, University of Western Ontario, Ontario, Canada

,

Lakshmikumar Venkatraghavan

⁴Department of Anesthesia, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada

› Institutsangaben

Abstract

A 51-year-old male with medically refractory Parkinson's disease was scheduled for bilateral deep brain stimulation (DBS). During microelectrode recordings (MERs) of right side DBS, the patient developed severe sustained whole-body tremors causing severe artefacts in MER. The right side DBS electrode was inserted with suboptimal MER. For the creation of left burr hole, propofol infusion at a rate of 20 μg/kg/min, was used and soon after, all tremor activity ceased. Propofol infusion was continued during left side MER. With the absence of tremors, left subthalamic nucleus spike activity was better identified and neurological testing could take place. At 6 months after DBS, the patient’s symptoms had improved significantly without the need for levodopa.

Keywords

a tremor effect - deep brain stimulation - Parkinson’s disease - propofol

Volltext

Referenzen

References
1 Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson’s disease.. Arch Neurol 1993; 50: 140-148
2 Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease.. Lancet Neurol 2009; 8: 67-81
3 Gross RE, Krack P, Rodriguez-Oroz MC, Rezai AR, Benabid AL. Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson’s disease and tremor.. Mov Disord 2006; 21 Suppl 14 S259-S283
4 Helmich RC, Toni I, Deuschl G, Bloem BR. The pathophysiology of essential tremor and Parkinson’s tremor.. Curr Neurol Neurosci Rep 2013; 13: 378
5 Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor.. Lancet Neurol 2011; 10: 148-161
6 Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced Parkinsonism.. Brain Res 1991; 547: 142-151
7 Vila M, Levy R, Herrero MT, Ruberg M, Faucheux B, Obeso JA. et al. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: An in situ hybridization study of cytochrome oxidase subunit I mRNA.. J Neurosci 1997; 17: 765-773
8 Ihara M, Tomimoto H, Ishizu K, Yoshida H, Sawamoto N, Hashikawa K. et al. Association of vascular Parkinsonism with impaired neuronal integrity in the striatum.. J Neural Transm (Vienna) 2007; 114: 577-584
9 Hall SD, Prokic EJ, McAllister CJ, Ronnqvist KC, Williams AC, Yamawaki N. GABA-mediated changes in inter-hemispheric beta frequency activity in early-stage Parkinson’s disease.. Neuroscience 2014; 281: 68-76
10 Anderson BJ, Marks PV, Futter ME. Propofol - Contrasting effects in movement disorders.. Br J Neurosurg 1994; 8: 387-8
11 Wright JJ, Goodnight PD, McEvoy MD. The utility of ketamine for the preoperative management of a patient with Parkinson’s disease.. Anesth Analg 2009; 108: 980-982
12 Raz A, Eimerl D, Zaidel A, Bergman H, Israel Z. Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.. Anesth Analg 2010; 111: 1285-1289
13 Sanghera MK, Grossman RG, Kalhorn CG, Hamilton WJ, Ondo WG, Jankovic J.. et al. Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy.. Neurosurgery 2003; 52: 1358-1370
14 Fluchere F, Witjas T, Eusebio A, Bruder N, Giorgi R, Leveque M. et al. Controlled general anaesthesia for subthalamic nucleus stimulation in Parkinson’s disease.. J Neurol Neurosurg Psychiatry 2014; 85: 1167-1173
15 Harries AM, Kausar J, Roberts SA, Mocroft AP, Hodson JA, Pall HS. et al. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: Long-term results.. J Neurosurg 2012; 116: 107-113
16 Lin SH, Chen TY, Lin SZ, Shyr MH, Chou YC, Hsieh WA. et al. Subthalamic deep brain stimulation after anesthetic inhalation in Parkinson disease: A preliminary study.. J Neurosurg 2008; 109: 238-244
17 Hertel F, Ziichner M, Weimar I, Gemmar P, Noll B, Bettag M. et al. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson’s disease with the aid of intraoperative microrecording under general anesthesia.. Neurosurgery 2006; 59: E1138
18 Maltête D, Navarro S, Welter ML, Roche S, Bonnet AM, Houeto JL. et al. Subthalamic stimulation in Parkinson disease: With or without anesthesia?. Arch Neurol 2004; 61: 390-392
19 Kim W, Song IH, Lim YH, Kim MR, Kim YE, Hwang JH. et al. Influence of propofol and fentanyl on deep brain stimulation of the subthalamic nucleus.. J Korean Med Sci 2014; 29: 1278-1286